Another miRNA, miR-210, was identified in a dataset of untreated patients consisting of 25 ER-, 40 ER+ and 8 ER-unknown tumor samples, and therefore likely represents a general marker for outcome [16], whereas our study focused on resistance towards Tamoxifen from the onset. Here, ESR1 is linked to neoplasm.